YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Merck & Co. Inc. announced plans to purchase biopharmaceutical company Tilos Therapeutics.
The deal for the cancer-treatment biotechnology firm could be valued at up to $773 million.
The deal includes an up-front payment and milestone payouts.
Read more from MarketWatch.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects